News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

TopoTarget A/S Confirms Receipt Of Acceptance-To-File Milestone Payment


3/27/2014 9:31:32 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Topotarget A/S hereby confirms the receipt of the milestone payment of USD 10 million and 1 million shares from Spectrum Pharmaceuticals, Inc. related to the US Food and Drug Administration’s (FDA) recent acceptance to file BeleodaqTM (belinostat) for peripheral T-cell lymphoma (PTCL).

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES